|
Originally published In Press as doi:10.1074/jbc.M107549200 on December 3, 2001
J. Biol. Chem., Vol. 277, Issue 6, 4104-4109, February 8, 2002
Bile Salt-stimulated Carboxyl Ester Lipase Influences Lipoprotein
Assembly and Secretion in Intestine
A PROCESS MEDIATED VIA CERAMIDE HYDROLYSIS*
R. Jason
Kirby,
Shuqin
Zheng,
Patrick
Tso,
Philip N.
Howles, and
David Y.
Hui
From the Department of Pathology and Laboratory Medicine,
University of Cincinnati College of Medicine,
Cincinnati, Ohio 45267
Received for publication, August 7, 2001, and in revised form, November 21, 2001
 |
ABSTRACT |
Bile salt-stimulated carboxyl ester lipase (CEL),
also called cholesterol esterase, is one of the major proteins secreted by the pancreas. The physiological role of CEL was originally thought
to be its mediation of dietary cholesterol absorption. However, recent
studies showed no difference between wild type and CEL knockout mice in
the total amount of cholesterol absorbed in a single meal. The current
study tests the hypothesis that CEL in the intestinal lumen may
influence the type of lipoproteins produced. A lipid emulsion
containing 4 mM phospholipid, 13.33 mM
[3H]triolein, and 2.6 mM
[14C]cholesterol in 19 mM taurocholate was
infused into the duodenum of lymph fistula CEL(+/+) and CEL( / ) mice
at a rate of 0.3 ml/h. Results showed no difference between CEL(+/+)
and CEL( / ) mice in the rate of cholesterol and triglyceride
transport from the intestinal lumen to the lymph. However, CEL( / )
mice produced predominantly smaller lipoproteins, whereas the CEL(+/+)
mice produced primarily large chylomicrons and very low density
lipoprotein. The proximal intestine of CEL( / ) mice was also found
to possess significantly less ceramide hydrolytic activity than that
present in CEL(+/+) mice. By using Caco2 cells grown on Transwell
membranes as a model, sphingomyelinase treatment inhibited the
secretion of larger chylomicron-like lipoproteins without affecting
total cholesterol secretion. In contrast, the addition of CEL to the apical medium increased the amount of large lipoproteins produced and
alleviated the inhibition induced by sphingomyelinase. Taken together,
this study identified a novel and physiologically significant role for
CEL, namely the promotion of large chylomicron production in the
intestine. The mechanism appears to be mediated through CEL hydrolysis
of ceramide generated during the lipid absorption process.
 |
INTRODUCTION |
Carboxyl ester lipase
(CEL),1 also called
cholesterol esterase and bile salt-stimulated lipase, is a 74-kDa
lipolytic enzyme capable of hydrolyzing cholesteryl esters,
triacylglycerol, phospholipids, and lysophospholipids (1, 2). The
enzyme is synthesized in the acinar cells of the pancreas and is stored
in zymogen granules. Upon food ingestion, CEL is released into the
intestinal lumen where it constitutes 1-5% of total protein in
pancreatic juice (3, 4). The same enzyme is also present as a major
protein in milk and as a minor constituent in liver, activated
macrophages, and endothelial cells (5-9).
The abundance of CEL in pancreatic juice and in milk of a number of
mammals led to the early speculation of its role in dietary lipid
absorption (10-12). However, the precise role of CEL in dietary lipid
absorption remains controversial despite over 20 years of investigations. For example, one study showed that infusion of pancreatic juice containing CEL, but not juice devoid of CEL by immunoprecipitation, restored normal cholesterol absorption in pancreatectomized rats (10, 13). On the other hand, another study
showed that cholesterol absorption was not affected by pancreatic diversion (14). In vitro tissue culture studies also failed to resolve this issue, with experiments showing that the inclusion of
CEL can either facilitate or have no effect on cholesterol transport by
the enterocyte-like Caco-2 cells (12, 15, 16). Although recent studies
with CEL gene-targeted mice demonstrated that CEL deficiency did not
alter the total amount of cholesterol absorbed from a bolus meal over a
24-h period (17, 18), whether CEL has any influence on the rate of
intestinal cholesterol absorption and/or the type of lipoproteins
produced in the intestine remains unknown.
One difficulty in assigning specific role(s) for each protein in lipid
absorption is the complexity of the process. After lipid digestion and
solubilization with bile salt micelles in the intestinal lumen
(19-22), lipid nutrients are absorbed by enterocytes, resynthesized,
and assembled into lipoproteins (a process that entails shuttling
through several intracellular compartments) prior to their secretion
into the lymph. The first step of this process is microsomal
triglyceride transfer protein-mediated lipidation of apoB in the lumen
of the smooth endoplasmic reticulum (23, 24). The lipid-poor apoB
particles fuse with apoB-free triacylglycerol-rich particles in the
rough endoplasmic reticulum (23, 24), and these partially matured
lipoproteins are then delivered to the Golgi for final processing prior
to secretion into the lymphatics (25).
Increasing evidence shows that the transport of pre-chylomicrons from
the endoplasmic reticulum to the Golgi is a vesicular process mediated
by pre-chylomicron transport vesicles (26). Recent studies (27, 28)
have shown that naturally occurring long chain ceramides, such as those
generated from sphingomyelin hydrolysis, are promoters of Golgi
disassembly and are capable of disrupting protein trafficking through
intracellular secretory pathways. In view of observations that CEL
possesses lipoamidase activity (29) and is capable of hydrolyzing
ceramide (30), this study was undertaken to test the possibility that
CEL may influence intestinal lipoprotein assembly and transport.
 |
EXPERIMENTAL PROCEDURES |
Materials--
Cholesterol, taurocholate, monooleylglycerol,
oleic acid, egg phosphatidylcholine, and triolein were obtained from
Sigma. [14C]Cholesterol and [3H]triolein
were purchased from PerkinElmer Life Sciences.
[3H]D-erythro-N-acetylsphingosine
(C6-ceramide) was purchased from American Radiolabeled
Chemicals, Inc. (St. Louis, MO). Bacterial sphingomyelinase (SMase) and
C6-ceramide were from Matreya, Inc. (Pleasant Gap, PA).
Human CEL was purified from human milk (generous gift from Dr. Ron
Jandecek, Procter & Gamble, Inc., Cincinnati, OH) using the same
procedure as described previously for the purification of rat
pancreatic CEL (7). Formvar-coated grids used for electron microscopy
were obtained from Electron Microscopy Sciences (Fort Washington, PA).
Free and total cholesterol analysis kits were purchased from Wako
Chemicals (Richmond, VA). The human colonic adenocarcinoma cell line
Caco2 cells was obtained from the American Type Culture Collection
(Manassas, VA; ATCC HTB 37). Costar Transwells (6-well; 3-µm pore)
were obtained from Fisher. Dulbecco's modified Eagle's medium with
4.5 g/liter glucose and fetal bovine serum were purchased from Invitrogen.
Lymphatic Lipid Transport--
Male C57BL/6 mice were purchased
from Jackson Laboratories (Bar Harbor, ME). The CEL( / ) mice were
produced and bred in our institutional animal facility. The
characteristics of these mice have been reported previously (17). Under
halothane anesthesia, the major intestinal lymph duct of CEL(+/+) and
CEL( / ) mice was cannulated superior to the superior mesenteric
artery as described (31, 32). The lymph cannula was primed with a
heparin sodium solution (1,000 units/ml) to prevent clotting. A
silicone tube was passed through the fundus of the stomach and extended
into the duodenum. The fundal incision was closed using a purse-string suture. Postoperatively, the animals were infused with a 5% dextrose saline solution (145 mM NaCl, 4 mM KCl, 0.28 mM dextrose) at a constant rate of 0.3 ml/h. The animals
were maintained overnight at 30 °C before lipid infusion. On the day
of experiments, mice were infused with an emulsion that consisted of 4 mM egg phosphatidylcholine, 13.33 mM
[3H]triolein, and 2.6 mM
[14C]cholesterol in 19 mM taurocholate at a
rate of 0.3 ml/h. Lymph was collected for 1 h prior to lipid
infusion and served as the fasting lymph. After beginning lipid
infusion, lymph was collected hourly for 6 h. Appearance of
radiolabel in lymph was determined by scintillation counting.
Lipoprotein Size Determination--
Lipoproteins from mesenteric
lymph were adsorbed onto 300-mesh Formvar-coated grids, air-dried, and
stained either with 1% phosphotungstic acid, pH 6.9, for 30 s or
dual stained with 4% osmium tetroxide and 1% phosphotungstic acid in
0.1% sucrose as described (33). Electron micrographs were taken of
random areas of several grids at a magnification of ×40,000 using a
Hitachi H-600 transmission electron microscope (Hitachi Ltd., Tokyo,
Japan). The diameters of 400 particles were measured from
representative photographs to determine particle sizes.
Ceramide Hydrolytic Activity--
Substrate for measuring
ceramide hydrolytic activity was prepared by dissolving 0.5 µmol of
unlabeled C-6 ceramide and 1 µCi of
[3H]C6-ceramide in ethanol and then dried
under nitrogen. The sample was resuspended in 10 ml of buffer
containing 20 mM Tris-HCl, pH 8.5, 4 mM
taurocholate and then sonicated for 10 min at 4 °C. Ceramidase assay
was commenced by adding 0.1 ml of purified CEL solution in
phosphate-buffered saline to 0.5 ml of the ceramide substrate.
Incubation was continued at 37 °C for 1 h. Reaction was
terminated by addition of 1 ml of 50 mM sodium borate, 50 mM sodium carbonate, pH 10.0. Fatty acids were extracted by
addition of 3 ml of methanol/chloroform/heptane (1.41:1.25:1.0, v/v/v) and centrifugation for 30 min at 5,000 × g. A 0.75-ml
aliquot of the top aqueous phase was added to 15 ml of scintillation
fluid for radioactivity determination in a scintillation counter.
Extraction efficiency was determined empirically to be 80%, which was
corrected in the report of results.
For the determination of ceramide hydrolytic activity in small
intestine, the tissue was removed from CEL(+/+) and CEL( / ) mice
immediately after their sacrifice. The intestine was flushed with cold
saline and then sectioned into four equal fractions proximal to distal.
The mucosa was scraped using glass microscope slides and suspended in 5 ml of buffer containing 300 mM mannitol, 1 mM
EGTA, 2.4 mM Tris-HCl, pH 7.1. Particulate fraction
containing brush border membranes was prepared by a modification of
Kessler's divalent cation precipitation method (34). Briefly, 20 ml of H2O was added to the mucosal scrapings for homogenization
with a Dounce homogenizer. A 0.25-ml aliquot of 1 M
MgCl2 was added to each homogenate, and the sample was
incubated on ice for 15 min prior to centrifugation at 3000 × g for 15 min. The resulting supernatant was centrifuged at
27,000 × g for 30 min. Pellet containing cellular
membrane proteins, including brush border membranes, was resuspended in
60 mM mannitol, 5 mM EGTA, 12 mM
Tris-HCl, pH 7.1. Protein content was determined by the Lowry procedure (35), and 50 µg of membrane proteins were used for ceramidase activity determinations.
Cell Culture--
Human Caco-2 cells were cultured in
Dulbecco's modified Eagle's medium containing 4.5 g/liter glucose,
15% fetal bovine serum, 1% L-glutamine, and 1%
penicillin/streptomycin at 37 °C in 10% CO2. Stock
cultures were maintained in 75-cm2 flasks, and medium was
changed every 3-4 days. The cells were seeded on polycarbonate
semi-permeable (3-µm pores) Transwell membranes in 6-well culture
dishes at 106 cells per well. Cultures were grown to 21-25
days post-confluency prior to experiments.
Lipid substrates containing 50 µM cholesterol, 30 µM monoolein, 1.6 mM oleic acid, and 1 mM taurocholate were prepared by drying contents under
N2 and dissolving in serum-free Dulbecco's modified
Eagle's medium by sonication. Trace amounts of
[14C]cholesterol were added to the micelles to monitor
cholesterol transport. SMase and CEL, in phosphate-buffered saline,
were added to micelle preparations at final concentrations of 100 milliunits/ml and 10 µg/ml, respectively. On the day of the
experiments, the Caco2 cells were washed twice with phosphate-buffered
saline. 2 ml of fresh serum-free Dulbecco's modified Eagle's medium
were added to the basolateral surface, and 2 ml of the micellar
preparations were added to the apical surface. Incubations were
continued at 37 °C for 24 h. At the end of the incubation
period, the basolateral medium was collected. An aliquot of the medium
was used for radioactivity determinations to measure cholesterol
secretion. Another aliquot of the basolateral medium was subjected to
density gradient ultracentrifugation for lipoprotein separation.
Differential Gradient Ultracentrifugation--
Basolateral
medium was collected and brought to 4 ml with serum-free Dulbecco's
modified Eagle's medium. Solid KBr was added to adjust the density to
1.10 g/ml. The sample was overlaid with 3 ml each of 1.063 and 1.019 g/ml, and 2 ml of 1.006 g/ml KBr density solutions and then centrifuged
for 33 min at 40,000 rpm in a Beckman SW41Ti rotor at 15 °C. Large
chylomicrons (with flotation rate of Sf > 400) were obtained from the top 1-ml fraction after centrifugation.
 |
RESULTS |
Lipid Absorption Rate and Lymph Lipoprotein Particle Size of
CEL(+/+) and
CEL( / ) Mice--
The role of
CEL in intestinal lipid transport was explored by comparing the rate of
lymphatic absorption of radiolabeled lipids that were infused into the
duodenum in lymph fistula CEL(+/+) and CEL( / ) mice. An emulsion
containing 4 mM phospholipid, 13.33 mM
[3H]triolein, and 2.6 mM
[14C]cholesterol in 19 mM taurocholate was
infused into each animal at a rate of 0.3 ml/h. Lymph was collected
hourly to monitor radiolabeled lipid output by the intestine. No
difference in the absorption rate of infused cholesterol from the
intestinal lumen to the mesenteric lymph was observed between CEL(+/+)
and CEL( / ) mice (Fig. 1A). Radiolabeled fatty acids derived from [3H]triolein were
also secreted into the lymph at a similar rate for both CEL(+/+) and
CEL( / ) mice (Fig. 1B). However, when lymph from these
animals was analyzed by negative staining electron microscopy, a
significant difference in the size of lipoprotein particles was
observed (Fig. 2). The CEL(+/+) mice
produced lipoproteins with sizes ranging from 40 to 260 nm (Fig. 2,
A and C). Approximately 55% of the lymph
lipoproteins displayed sizes >80 nm indicating a predominance of
chylomicron production in the wild type mice. In contrast, lymph
lipoproteins in CEL( / ) mice were much smaller, ranging in size from
20 to 140 nm (Fig. 2, B and D). Less than 25% of
the lymph lipoproteins in CEL( / ) mice were the size of large
chylomicrons (>80 nm). Most of the lymph lipoproteins (75%) in
CEL( / ) mice were 30-80 nm in diameter, suggesting that the intestines of CEL( / ) mice secrete mostly VLDL sized lipoproteins. Analysis of the cholesterol content in the lymph of these animals revealed a higher percentage of the cholesterol was esterified in
CEL( / ) mice in comparison with that observed in CEL(+/+) mice (66 versus 45%, respectively). Thus, the difference in
lipoprotein particle size observed in CEL(+/+) and CEL( / ) mice
cannot be attributed to the cholesteryl ester hydrolytic activity of
CEL.

View larger version (16K):
[in this window]
[in a new window]
|
Fig. 1.
Lipid transport from intestinal lumen to
lymphatics in mice. Lymph fistula of control (filled
symbols) and CEL( / ) (open symbols) mice were
infused with a lipid emulsion containing 4 mM egg
phosphatidylcholine, 13.33 mM [3H]triolein,
and 2.6 mM [14C]cholesterol in 19 mM taurocholate at a rate of 0.3 ml/h. Lymph was collected
hourly for liquid scintillation counting to determine the amount of
[14C]cholesterol (A) or
[3H]oleate (B) absorbed. The data represent
means ± S.D. from three separate experiments.
|
|

View larger version (78K):
[in this window]
[in a new window]
|
Fig. 2.
Size distribution of lymph lipoproteins from
control and CEL-null mice. Lymph was collected from CEL(+/+)
(A and C) and CEL( / ) (B and
D) lymph fistula mice 4 h after the onset of duodenal
lipid infusion. The samples were adhered to 300-mesh Formvar grids and
stained with either 1% phosphotungstic acid, pH 6.9 (A), or
dual stained with 4% osmium tetroxide and 1% phosphotungstic acid in
0.1% sucrose (B). Magnification = ×40,000 with the
bars indicating 200 nm in length. Approximately 300-400
particles were counted from representative micrographs, and collective
results are shown for lipoprotein particle size in CEL(+/+)
(C) and CEL( / ) (D) mice.
|
|
Ceramidase Activity of CEL--
Previous studies (36, 37) with
cultured intestinal cells suggested that intestinal lipoprotein
secretion may be controlled by ceramide release after membrane
sphingomyelin hydrolysis. In view of our previous observation (29) that
CEL also displays lipoamidase activity, experiments were performed to
determine whether CEL influences ceramide metabolism in intestine. An
initial study (30) was performed to confirm the ceramide hydrolytic activity of CEL. Incubation of C6-ceramide with CEL
resulted in a CEL concentration-dependent release of free fatty
acids from ceramide (Fig. 3). We then
compared ceramide hydrolytic activity in the intestine of CEL(+/+) and
CEL( / ) mice. Membrane proteins prepared from the proximal
intestinal mucosa of CEL(+/+) mice were found to contain approximately
twice the ceramide hydrolytic activity as that present in similar
preparations from CEL( / ) mice (Fig.
4). In contrast, ceramide hydrolytic
activity in membrane preparations from the mid- to distal intestinal
fractions was similar between CEL(+/+) and CEL( / ) mice (Fig. 4).
Because intestinal lipid absorption occurs primarily in the proximal
intestine (38), these results support the hypothesis that the CEL
influence on intestinal lipoprotein assembly and transport may be
related to the ceramidase activity of this protein.

View larger version (10K):
[in this window]
[in a new window]
|
Fig. 3.
Ceramide hydrolysis by purified human
CEL. Fifty nmol/ml [3H]C6-ceramide (2 Ci/mol) was incubated at 37 °C for 1 h with purified human CEL
at the indicated concentration in buffer containing 20 mM
Tris-HCl, pH 8.5, 4 mM taurocholate. The reaction was
terminated by addition of 1 ml of buffer containing 50 mM
sodium borate and 50 mM sodium carbonate, pH 10. The
liberated fatty acids were extracted with 3 ml of
methanol/chloroform/heptane (1.41:1.25:1.0; v/v/v). An aliquot of the
extract was used for radioactivity determinations. The data represent
means ± S.D. from three different experiments.
|
|

View larger version (15K):
[in this window]
[in a new window]
|
Fig. 4.
Ceramide hydrolytic activity in intestinal
homogenates from CEL(+/+) and
CEL( / ) mice. Small
intestine from CEL(+/+) mice (closed bars) and CEL( / )
mice (open bars) were flushed with phosphate-buffered
saline, excised, and sectioned proximal to distal into four equally
spaced sections. Mucosal homogenates and membrane proteins were
prepared. Ceramide hydrolytic activity was determined by incubating 50 µg of membrane proteins with [3H]C-6 ceramide as
described in the legend to Fig. 3. Data represent means ± S.D.
(n = 3-4). * denotes significant difference from
CEL(+/+) mice at p < 0.05.
|
|
Effect of Ceramide Accumulation and CEL on Lipid Transport in
Caco-2 Cell Culture--
The effect of CEL on chylomicron assembly and
secretion was further examined in differentiated Caco-2 cells grown on
polycarbonate Transwell membranes. Micelles containing 50 µM [14C]cholesterol, 30 µM
monoolein, 1.6 mM oleic acid, and 1 mM
taurocholate suspended in serum-free media were incubated on the apical
surface of the cells in the presence or absence of bacterial SMase with or without CEL. Transport was monitored by the appearance of radiolabel in the basolateral media. Secreted lipoproteins were then fractionated by differential gradient ultracenrifugation to separate chylomicrons from higher density particles. Consistent with results reported by
Luchoomun and Hussain (39), the incubation of differentiated Caco-2
cells with oleic acid-supplemented medium resulted in the secretion of
large chylomicron-sized lipoproteins. Incubation of Caco-2 cells with
the micellar substrate in the presence or absence of CEL had no effect
on the total amount of cholesterol secreted into the basolateral media
(Fig. 5A). However, the amount of micellar derived [14C]cholesterol secreted into the
basolateral media as the low density large chylomicron fractions was
found to be increased in the incubations containing CEL (Fig.
5B). In contrast, generation of endogenous ceramide in Caco2
cells by incubation with bacterial SMase decreased the amount of
micelle-derived [14C]cholesterol found in the
larger chylomicron-like particles (Fig. 5B) without
significant effect on the total amount of
[14C]cholesterol secreted into the basolateral media
(Fig. 5A). Interestingly, the addition of CEL not only
alleviated the SMase inhibition of large chylomicron secretion, but the
amount of [14C]cholesterol in the chylomicron fraction
was also higher in incubations containing both CEL and SMase than in
control cells incubated without these proteins or with only CEL (Fig.
5B).

View larger version (13K):
[in this window]
[in a new window]
|
Fig. 5.
Effect of carboxyl ester lipase and bacterial
sphingomyelinase on cholesterol secretion from differentiated Caco-2
cells. The Caco-2 cells were cultured to post-confluency on
Transwell membranes in 6-well culture dishes. Serum-free media
containing 2 ml of micelles (50 µM
[14C]cholesterol, 30 µM monoolein, 1.6 mM oleic acid, 1 mM taurocholate) were added to
the apical compartment, and the incubation was continued for 24 h
at 37 °C. When included, SMase and CEL in phosphate-buffered saline
were added at a concentration of 100 milliunits/ml and 10 µg/ml,
respectively. An equivalent volume of buffer without enzyme was added
to the control wells. At the end of the incubation period, an aliquot
of the basolateral media was used for radioactivity measurement to
determine the total amount of [3H]cholesterol secreted by
the Caco-2 cells (A). The remaining portion of the
basolateral media was subjected to differential gradient
ultracentrifugation to isolate chylomicron particles
(Sf > 400) (B). The reported data
represent the mean ± S.D. from three different experiments.
Bars with different letters are significantly
different from each other at p < 0.05.
|
|
 |
DISCUSSION |
Lipid absorption occurs predominantly in the proximal part of the
intestine (38) and continues into the distal intestine after a high fat
load (40). Interestingly, CEL secreted by the pancreas is also present
in absorptive cells throughout the small intestine and is especially
prominent in the proximal gut (41). Although this CEL localization
suggests its possible involvement in dietary lipid absorption and
transport, its precise role in the lipid absorption process has not
been defined. This study identified a novel physiologic role of CEL in
dictating the type of lipoproteins produced by the intestine. We used
CEL-null mice to demonstrate that the lack of a functional CEL gene
resulted in diminished production of large sized chylomicrons and the
concomitant increase in the amount of smaller VLDL sized intestinal
lipoproteins after lipid infusion in vivo. The lack of CEL
in the CEL( / ) mice may either directly result in defective lipid
processing in the intestine or alternatively delaying lipid absorption
to the distal portion of the intestine where the smaller sized VLDL may
be produced. Although we cannot distinguish these possibilities in the
current study, previous studies indicated that lipoproteins secreted by
distal intestine were either larger (42) or the same size (43) as
chylomicrons secreted by the proximal intestine. Therefore, it seems
likely that CEL directly influences lipoprotein assembly and secretion
in the proximal intestine and dictates the type of lipoproteins being
produced. The in vitro cell culture experiments showing that
addition of CEL increases the production of large sized
chylomicron-like particles by Caco-2 cells are supportive of this hypothesis.
Our current study also showed reduced ceramide hydrolytic activity in
the proximal intestine of CEL( / ) mice. This observation suggests
that CEL may promote chylomicron production through ceramide hydrolysis. The importance of sphingomyelin and its metabolic product
ceramide in controlling lipid trafficking in mammalian cells is well
documented in the literature. Previously, Field and colleagues (44, 45)
showed that cholesterol uptake by enterocytes is a two-step process in
which the first step requires micellar cholesterol from the apical side
embedding into the plasma membrane of the enterocytes. The
membrane-bound cholesterol is then transported to endoplasmic reticulum
where lipoprotein assembly occurs (44, 45). The amount of cholesterol
that can be accommodated in plasma membrane is strongly correlated with
its sphingomyelin content, and influx of membrane cholesterol into the
cell interior requires hydrolysis of the membrane sphingomyelin (46,
47). However, cell culture studies showed that the rate of exogenous cholesterol uptake by intestinal cells decreased when SMase was added
to the culture media (37). Although SMase also decreased the amount of
triacylglycerol secreted to the basolateral media, the amount of
cholesterol and phospholipid secreted into the basolateral media was
not affected by SMase treatment (36, 37). Analysis of the lipoprotein
composition data reported in these studies revealed that SMase may
affect the secretion of larger sized chylomicrons with minimal effect
on the secretion of smaller size VLDL. The SMase-induced alteration in
intestinal cholesterol transport was attributed to the ability of the
digestion product, ceramide, to inhibit basolateral secretion of
intestinal lipoproteins (36). Although the exact mechanism by which
ceramide inhibits chylomicron production is unknown at the present
time, it is likely that the excess ceramide generated during
cholesterol transport promotes Golgi disassembly and interrupts the
transport of pre-chylomicron transport vesicles to this organelle.
The previous in vitro cell culture experiments cited above
were conducted in the absence of other pancreatic enzymes. In a physiological setting, pancreatic enzymes including CEL are secreted into the pancreatic juice and are present in the intestinal lumen. The
CEL can interact with heparin-like molecules on the surface of
enterocytes (12) and be taken up into the cell interior (15, 48-50).
The presence of CEL may alleviate ceramide inhibition of intracellular lipid trafficking and promote chylomicron production. Thus, SMase hydrolysis of membrane sphingomyelin, along with CEL hydrolysis of ceramide, are two important processes in the
intracellular lipid transport process that are required for the
production of large chylomicrons in the intestine. The observed
synergism between SMase and CEL in promoting large chylomicron
secretion by Caco-2 cells in culture is supportive of this hypothesis.
A schematic diagram showing the participation of both SMase and CEL in
intestinal lipid transport and lipoprotein assembly is presented in
Fig. 6. We hypothesize that ceramide
generated as a result of sphingomyelin hydrolysis, by either luminal or
cytoplasmic SMase (37, 51), can be further hydrolyzed by CEL in the
lumen or endocytosed into the cell interior (15, 48-50). The
hydrolysis of this SMase-generated metabolic product is necessary for
proper lipid trafficking through the Golgi and the assembly and
secretion of large sized chylomicrons.

View larger version (15K):
[in this window]
[in a new window]
|
Fig. 6.
Schematic diagram depicting the proposed
participation of SMase and CEL in cholesterol transport in
enterocytes. This diagram shows that the initial step of
cholesterol absorption is the intercalation of the micellar cholesterol
from the lumen to the apical membrane of enterocytes. The second step
of cholesterol transport from the plasma membrane to the cell interior
requires the hydrolysis of the sphingomyelin by SMase present in the
intestinal lumen or in the cell interior. Ceramide generated as a
result of sphingomyelin hydrolysis can then be hydrolyzed by CEL
present in either the lumen (or membrane-bound) or CEL endocytosed into
the cells. Lack of ceramide hydrolysis will result in blockage of large
lipoprotein assembly and secretion by the intestinal cells.
|
|
It is important to note that ceramide hydrolytic activity in CEL( / )
mice decreased by ~50% only in the proximal intestine, with little
or no change in the distal gut. These results, which are consistent
with results reported by others (52), indicated the presence of
additional enzyme(s) in the intestine capable of ceramide hydrolysis.
However, the intestinal ceramidase is apparently unable to compensate
for the lack of CEL in promoting chylomicron assembly and secretion in
the CEL( / ) mice. It is possible that differences in anatomic
location of the two enzymes in the intestine (52) may account for the
inability of the ceramidase to replace CEL in mediating large
chylomicron production. It is also possible that the remaining
ceramidase activity in the proximal intestine of CEL( / ) mice is
insufficient to support the assembly and secretion of large
chylomicrons after lipid infusion. The differentiation of these two
possibilities will require additional experimentation with the
generation of tissue-specific ceramidase overexpression transgenic mice.
The participation of CEL in chylomicron production may be of clinical
importance in determining the relationship between dietary lipid
transport and risk of atherosclerosis and obesity. Previous studies
using in vitro generated lipoproteins with sizes comparable with large chylomicrons (Sf >400) and the smaller
VLDL (Sf = 20 = 400) showed that the
chylomicrons are cleared from circulation by the liver more rapidly
than the smaller sized VLDL (53-56). The delayed hepatic clearance of
smaller postprandial lipoproteins may promote obesity due to increase
transport of the dietary fat to adipose tissues. The smaller sized VLDL
are also more likely to penetrate the arterial wall. The VLDL trapped within the subendothelial space may promote atherogenesis (57). Thus,
CEL in the gastrointestinal tract may protect against these adverse
effects by promoting the formation of large chylomicrons in response to
fat feeding. Additional studies comparing diet-induced obesity and
atherosclerosis in CEL(+/+) and CEL( / ) mice are warranted.
 |
ACKNOWLEDGEMENTS |
We thank Dr. Brian Nordskog for numerous
discussions and assistance in sample preparation for the negative
staining electron microscopy data. The expert assistance of Richard
Montaine, Jay Card, and the University of Cincinnati Electron
Microscopy facility is gratefully appreciated.
 |
FOOTNOTES |
*
This work was supported by National Institutes of Health
Grants DK54504 and HL66246.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed: Dept. of Pathology and
Laboratory Medicine, University of Cincinnati College of Medicine, 231 Albert Sabin Way, Cincinnati, OH 45267-0529. Tel.: 513-558-9152; Fax:
513-558-2141; E-mail: Huidy@email.uc.edu.
Published, JBC Papers in Press, December 3, 2001, DOI 10.1074/jbc.M107549200
 |
ABBREVIATIONS |
The abbreviations used are:
CEL, bile
salt-stimulated carboxyl ester lipase;
C6-ceramide, D-erythro-N-acetylsphingosine;
apoB, apolipoprotein B;
SMase, sphingomyelinase;
VLDL, very low density
lipoprotein.
 |
REFERENCES |
| 1.
|
Wang, C. S.,
and Hartsuck, J. A.
(1993)
Biochim. Biophys. Acta
1166,
1-19[Medline]
[Order article via Infotrieve]
|
| 2.
|
Hui, D. Y.
(1996)
Biochim. Biophys. Acta
1303,
1-14[Medline]
[Order article via Infotrieve]
|
| 3.
|
Blackberg, L.,
Lombardo, D.,
Hernell, O.,
Guy, O.,
and Olivecrona, T.
(1981)
FEBS Lett.
136,
284-288[CrossRef][Medline]
[Order article via Infotrieve]
|
| 4.
|
Wang, C.,
and Kloer, H.
(1983)
Biochim. Biophys. Acta
754,
142-149[Medline]
[Order article via Infotrieve]
|
| 5.
|
Harrison, E. H.
(1988)
Biochim. Biophys. Acta
963,
28-34[Medline]
[Order article via Infotrieve]
|
| 6.
|
Winkler, K. E.,
Harrison, E. H.,
Marsh, J. B.,
Glick, J. M.,
and Ross, A. C.
(1992)
Biochim. Biophys. Acta
1126,
151-158[Medline]
[Order article via Infotrieve]
|
| 7.
|
Camulli, E. A.,
Linke, M. J.,
Brockman, H. L.,
and Hui, D. Y.
(1989)
Biochim. Biophys. Acta
1005,
177-182[Medline]
[Order article via Infotrieve]
|
| 8.
|
Li, F.,
and Hui, D. Y.
(1997)
J. Biol. Chem.
272,
28666-28671[Abstract/Free Full Text]
|
| 9.
|
Li, F.,
and Hui, D. Y.
(1998)
Biochem. J.
329,
675-679
|
| 10.
|
Gallo, L. L.,
Newbill, T.,
Hyun, J.,
Vahouny, G. V.,
and Treadwell, C. R.
(1977)
Proc. Soc. Exp. Biol. Med.
156,
277-281[CrossRef][Medline]
[Order article via Infotrieve]
|
| 11.
|
Bhat, S. G.,
and Brockman, H. L.
(1982)
Biochem. Biophys. Res. Commun.
109,
486-492[CrossRef][Medline]
[Order article via Infotrieve]
|
| 12.
|
Bosner, M. S.,
Gulick, T.,
Riley, D. J. S.,
Spilburg, C. A.,
and Lange, L. G.
(1988)
Proc. Natl. Acad. Sci. U. S. A.
85,
7438-7442[Abstract/Free Full Text]
|
| 13.
|
Gallo, L. L.,
Clark, S. B.,
Myers, S.,
and Vahouny, G. V.
(1984)
J. Lipid Res.
25,
604-612[Abstract]
|
| 14.
|
Watt, S. M.,
and Simmonds, W. J.
(1981)
J. Lipid Res.
22,
157-165[Abstract]
|
| 15.
|
Huang, Y.,
and Hui, D. Y.
(1990)
J. Lipid Res.
31,
2029-2037[Abstract]
|
| 16.
|
Shamir, R.,
Johnson, W. J.,
Zolfaghari, R.,
Lee, H. S.,
and Fisher, E. A.
(1995)
Biochemistry
34,
6351-6358[CrossRef][Medline]
[Order article via Infotrieve]
|
| 17.
|
Howles, P. N.,
Carter, C. P.,
and Hui, D. Y.
(1996)
J. Biol. Chem.
271,
7196-7202[Abstract/Free Full Text]
|
| 18.
|
Weng, W., Li, L.,
van Bennekum, A. M.,
Potter, S. H.,
Harrison, E. H.,
Blaner, W. S.,
Breslow, J. L.,
and Fisher, E. A.
(1999)
Biochemistry
38,
4143-4149[CrossRef][Medline]
[Order article via Infotrieve]
|
| 19.
|
Hernell, O.
(1990)
Acta Pediatr. Scand.
365 (suppl.),
20-27
|
| 20.
|
Hernell, O.,
Staggers, J. E.,
and Carey, M. C.
(1990)
Biochemistry
29,
2041-2056[CrossRef][Medline]
[Order article via Infotrieve]
|
| 21.
|
Carey, M. C.,
and Hernell, O.
(1992)
Semin. Gastrointest. Dis.
3,
189-208
|
| 22.
|
Carey, M. C.,
Small, D. M.,
and Bliss, C. M.
(1983)
Am. Rev. Physiol.
45,
651-677[CrossRef][Medline]
[Order article via Infotrieve]
|
| 23.
|
Hamilton, R. L.,
Erickson, S. K.,
and Havel, R. J.
(1995)
Atherosclerosis
10,
414-418
|
| 24.
|
Hamilton, R. L.,
Wong, J. S.,
Cham, C. M.,
Nielsen, L. B.,
and Young, S. G.
(1998)
J. Lipid Res.
39,
1543-1557[Abstract/Free Full Text]
|
| 25.
|
Mansbach, C. M.,
and Nevin, P.
(1998)
J. Lipid Res.
39,
963-968[Abstract/Free Full Text]
|
| 26.
|
Kumar, N. S.,
and Mansbach, C. M.
(1999)
Am. J. Physiol.
276,
G378-G386[Abstract/Free Full Text]
|
| 27.
|
Fukunaga, T.,
Nagahama, M.,
Hatsuzawa, K.,
Tani, K.,
Yamamoto, A.,
and Tagaya, M.
(2000)
J. Cell Sci.
113,
3299-3307[Abstract]
|
| 28.
|
Rosenwald, A. G.,
and Pagano, R. E.
(1993)
J. Biol. Chem.
268,
4577-4579[Abstract/Free Full Text]
|
| 29.
|
Hui, D. Y.,
Hayakawa, K.,
and Oizumi, J.
(1993)
Biochem. J.
291,
65-69
|
| 30.
|
Nyberg, L.,
Farooqi, A.,
Blackberg, L.,
Duan, R. D.,
Nilsson, A.,
and Hernell, O.
(1998)
J. Pediatr. Gastroenterol. Nutr.
27,
560-567[CrossRef][Medline]
[Order article via Infotrieve]
|
| 31.
|
Tso, P.,
and Simmonds, W. J.
(1984)
in
Lipid Research Methodology
(Story, J. A., ed)
, pp. 191-216, Alan R. Liss, Inc., New York
|
| 32.
|
Richmond, B. L.,
Boileau, A. C.,
Zheng, S.,
Huggins, K. W.,
Granholm, N. A.,
Tso, P.,
and Hui, D. Y.
(2001)
Gastroenterology
120,
1193-1202[CrossRef][Medline]
[Order article via Infotrieve]
|
| 33.
|
Anderson, L. J.,
Boyles, J. K.,
and Hussain, M. M.
(1989)
J. Lipid Res.
30,
1819-1824[Abstract]
|
| 34.
|
Rigtrup, K. M.,
and Ong, D. E.
(1992)
Biochemistry
31,
2920-2926[CrossRef][Medline]
[Order article via Infotrieve]
|
| 35.
|
Lowry, O. H.,
Rosebrough, N. J.,
Farr, A. L.,
and Randall, R. J.
(1951)
J. Biol. Chem.
193,
265-275[Free Full Text]
|
| 36.
|
Field, F. J.,
Chen, H.,
Born, E.,
Dixon, B.,
and Mathur, S.
(1993)
J. Clin. Invest.
92,
2609-2619
|
| 37.
|
Chen, H.,
Born, E.,
Mathur, S. N.,
Johlin, F. C.,
and Field, F. J.
(1992)
Biochem. J.
286,
771-777
|
| 38.
|
Sylven, C.,
and Nordstrom, C.
(1970)
Scand. J. Gastroenterol.
5,
57-63[Medline]
[Order article via Infotrieve]
|
| 39.
|
Luchoomun, J.,
and Hussain, M. M.
(1999)
J. Biol. Chem.
274,
19565-19572[Abstract/Free Full Text]
|
| 40.
|
Lin, H. C.,
Zhao, X. T.,
and Wang, L.
(1996)
Am. J. Physiol.
271,
G62-G67[Abstract/Free Full Text]
|
| 41.
|
Poorkhalkali, N.,
Lidmer, A. S.,
Lundberg, L. G.,
Dalrymple, M. A.,
Gibson, Y.,
Taylor, L.,
Temperley, S.,
Stromqvist, M.,
and Helander, H. F.
(1998)
Histochem. Cell Biol.
110,
367-376[CrossRef][Medline]
[Order article via Infotrieve]
|
| 42.
|
Wu, A. L.,
Bennett Clark, S.,
and Holt, P. R.
(1980)
J. Clin. Nutr.
33,
582-589
|
| 43.
|
Sabesin, S. M.,
Holt, P. R.,
and Clark, S. B.
(1975)
Lipids
10,
840-846[CrossRef][Medline]
[Order article via Infotrieve]
|
| 44.
|
Field, F. J.,
Born, E.,
and Mathur, S. N.
(1995)
J. Lipid Res.
36,
2651-2660[Abstract]
|
| 45.
|
Field, F. J.,
Born, E.,
and Mathur, S. N.
(1997)
J. Lipid Res.
38,
348-360[Abstract]
|
| 46.
|
Slotte, J. P.,
and Bierman, E. L.
(1988)
Biochem. J.
250,
653-658[Medline]
[Order article via Infotrieve]
|
| 47.
|
Gupta, A. K.,
and Rudney, H.
(1991)
J. Lipid Res.
32,
125-136[Abstract]
|
| 48.
|
Gallo, L. L.,
Chiang, Y.,
Vahouny, G. V.,
and Treadwell, C. R.
(1980)
J. Lipid Res.
21,
537-545[Abstract]
|
| 49.
|
Lechene de la Porte, P.,
Abouakil, N.,
Lafont, H.,
and Lombardo, D.
(1987)
Biochim. Biophys. Acta
920,
237-246[Medline]
[Order article via Infotrieve]
|
| 50.
|
Bruneau, N.,
Lombardo, D.,
and Bendayan, M.
(2000)
J. Histochem. Cytochem.
48,
267-276[Abstract/Free Full Text]
|
| 51.
|
Duan, R. D.,
Nyberg, L.,
and Nillson, A.
(1995)
Biochim. Biophys. Acta
1259,
49-55[Medline]
[Order article via Infotrieve]
|
| 52.
|
Duan, R. D.,
Cheng, Y.,
Yang, L.,
Ohlsson, L.,
and Nilsson, A.
(2001)
Lipids
36,
807-812[Medline]
[Order article via Infotrieve]
|
| 53.
|
Quartfordt, S. H.,
and Goodman, D. S.
(1966)
Biochim. Biophys. Acta
116,
383-385
|
| 54.
|
Chajek-Shaul, T.,
Eisenberg, S.,
Oschry, Y.,
and Olivercrona, T.
(1983)
J. Lipid Res.
24,
831-840[Abstract]
|
| 55.
|
Guldur, T.,
and Mayes, P. A.
(1992)
Biochem. Soc. Trans.
20,
104
|
| 56.
|
Martins, I. J.,
Mortimer, B. C.,
and Redgrave, T. G.
(1996)
J. Lipid Res.
37,
2696-2705[Abstract]
|
| 57.
|
Mamo, J. C.,
Proctor, S. D.,
and Smith, D.
(1998)
Atherosclerosis
141,
63-69[CrossRef]
|
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
S. A. Siddiqi and C. M. Mansbach II
PKC{zeta}-mediated phosphorylation controls budding of the pre-chylomicron transport vesicle
J. Cell Sci.,
July 15, 2008;
121(14):
2327 - 2338.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Gilham, E. D. Labonte, J. C. Rojas, R. J. Jandacek, P. N. Howles, and D. Y. Hui
Carboxyl Ester Lipase Deficiency Exacerbates Dietary Lipid Absorption Abnormalities and Resistance to Diet-induced Obesity in Pancreatic Triglyceride Lipase Knockout Mice
J. Biol. Chem.,
August 24, 2007;
282(34):
24642 - 24649.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Kono, J. L. Dreier, J. M. Ellis, M. L. Allende, D. N. Kalkofen, K. M. Sanders, J. Bielawski, A. Bielawska, Y. A. Hannun, and R. L. Proia
Neutral Ceramidase Encoded by the Asah2 Gene Is Essential for the Intestinal Degradation of Sphingolipids
J. Biol. Chem.,
March 17, 2006;
281(11):
7324 - 7331.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Nilsson and R.-D. Duan
Absorption and lipoprotein transport of sphingomyelin
J. Lipid Res.,
January 1, 2006;
47(1):
154 - 171.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Kodvawala, A. B. Ghering, W. S. Davidson, and D. Y. Hui
Carboxyl Ester Lipase Expression in Macrophages Increases Cholesteryl Ester Accumulation and Promotes Atherosclerosis
J. Biol. Chem.,
November 18, 2005;
280(46):
38592 - 38598.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Hu, D. Friedman, S. Hill, R. Caprioli, W. Nicholson, A. C Powers, L. Hunter, and L. E Limbird
Proteomic exploration of pancreatic islets in mice null for the {alpha}2A adrenergic receptor
J. Mol. Endocrinol.,
August 1, 2005;
35(1):
73 - 88.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Olsson, R.-D. Duan, L. Ohlsson, and A. Nilsson
Rat intestinal ceramidase: purification, properties, and physiological relevance
Am J Physiol Gastrointest Liver Physiol,
October 1, 2004;
287(4):
G929 - G937.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. K. Noh and S. I. Koo
Milk Sphingomyelin Is More Effective than Egg Sphingomyelin in Inhibiting Intestinal Absorption of Cholesterol and Fat in Rats
J. Nutr.,
October 1, 2004;
134(10):
2611 - 2616.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. M. Camarota, J. M. Chapman, D. Y. Hui, and P. N. Howles
Carboxyl Ester Lipase Cofractionates with Scavenger Receptor BI in Hepatocyte Lipid Rafts and Enhances Selective Uptake and Hydrolysis of Cholesteryl Esters from HDL3
J. Biol. Chem.,
June 25, 2004;
279(26):
27599 - 27606.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. J. Kirby, P. N. Howles, and D. Y. Hui
Rate of gastric emptying influences dietary cholesterol absorption efficiency in selected inbred strains of mice
J. Lipid Res.,
January 1, 2004;
45(1):
89 - 98.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. K. Noh and S. I. Koo
Egg Sphingomyelin Lowers the Lymphatic Absorption of Cholesterol and {alpha}-Tocopherol in Rats
J. Nutr.,
November 1, 2003;
133(11):
3571 - 3576.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Fayard, K. Schoonjans, J.-S. Annicotte, and J. Auwerx
Liver Receptor Homolog 1 Controls the Expression of Carboxyl Ester Lipase
J. Biol. Chem.,
September 12, 2003;
278(37):
35725 - 35731.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Bruneau, S. Richard, F. Silvy, A. Verine, and D. Lombardo
Lectin-like Ox-LDL Receptor Is Expressed in Human INT-407 Intestinal Cells: Involvement in the Transcytosis of Pancreatic Bile Salt-dependent Lipase
Mol. Biol. Cell,
July 1, 2003;
14(7):
2861 - 2875.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R.-D. Duan, Y. Cheng, G. Hansen, E. Hertervig, J.-J. Liu, I. Syk, H. Sjostrom, and A. Nilsson
Purification, localization, and expression of human intestinal alkaline sphingomyelinase
J. Lipid Res.,
June 1, 2003;
44(6):
1241 - 1250.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Y. Hui and P. N. Howles
Carboxyl ester lipase: structure-function relationship and physiological role in lipoprotein metabolism and atherosclerosis
J. Lipid Res.,
December 1, 2002;
43(12):
2017 - 2030.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|